Allen Mooney & Barnes Investment Advisors’s TJX Companies TJX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
1,632
-1,077
-40% -$170K 0.04% 140
2026
Q1
$433K Buy
2,709
+196
+8% +$30.5K 0.06% 112
2025
Q4
$386K Buy
2,513
+181
+8% +$26.8K 0.06% 115
2025
Q3
$337K Buy
2,332
+4
+0.2% +$531 0.05% 124
2025
Q2
$287K Buy
2,328
+4
+0.2% +$507 0.05% 132
2025
Q1
$283K Buy
2,324
+4
+0.2% +$486 0.05% 133
2024
Q4
$280K Buy
2,320
+3
+0.1% +$358 0.05% 134
2024
Q3
$272K Buy
2,317
+4
+0.2% +$459 0.05% 133
2024
Q2
$255K Buy
2,313
+4
+0.2% +$403 0.05% 137
2024
Q1
$221K Buy
2,309
+4
+0.2% +$388 0.04% 150
2023
Q4
$216K Buy
2,305
+34
+1% +$3.05K 0.04% 148
2023
Q3
$202K Buy
+2,271
New +$200K 0.04% 144

Other funds holding TJX

Allen Mooney & Barnes Investment Advisors's TJX Position: Q2 2026 in Review

Allen Mooney & Barnes Investment Advisors reduced its TJX Companies (TJX) stake by 40% in Q2 2026, selling an estimated $170K and leaving 1,632 shares worth $247K. The position accounts for 0.04% of the portfolio, ranked #140.

Allen Mooney & Barnes Investment Advisors first reported a position in TJX in Q3 2023 and has held it in 12 quarters since. The position peaked at $433K in Q1 2026. 2,732 funds tracked by Wall St. Rank hold TJX as of Q2 2026.

  • Allen Mooney & Barnes Investment Advisors held 1,632 shares of TJX Companies worth $247K as of Q2 2026.
  • Allen Mooney & Barnes Investment Advisors sold 1,077 TJX Companies shares in Q2 2026, an estimated $170K.
  • TJX Companies made up 0.04% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #140 holding.
  • Allen Mooney & Barnes Investment Advisors first reported a position in TJX Companies in Q3 2023 and has held it in 12 quarters since.
  • Allen Mooney & Barnes Investment Advisors's TJX Companies position peaked at $433K in Q1 2026.
  • 2,732 funds tracked by Wall St. Rank held TJX Companies as of Q2 2026.

Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.